2023-08-02 15:35:39 ET
- Dice Therapeutics ( NASDAQ: DICE ) quicky rose 0.5% amid a Nasdaq delisting notice for its $2.4 billion sale to Eli Lilly ( NYSE: LLY ).
- Dice ( DICE ) stock will be halted immediately after the close on Aug. 8 with the transaction tentaitively scheduled to close prior to the market open on Aug. 9, accordng to a Nasdaq notice on Wednesday.
- Eli Lilly ( LLY ) agreed to buy acquire Dice Therapeutics ( DICE ), a developer of oral therapeutics for immunological conditions, for $48 a share in cash in June.
For further details see:
Dice Therapeutics gains amid Nasdaq delisting notice for Eli Lilly deal